Invesaro

Stocks Health care ILMN

NASDAQ · Health care

Illumina, Inc. (ILMN)

Operating cash flow minus capital spending left $931M of free cash flow in fiscal 2025. At June 28, 2026 it held $1B in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 31, 2026.

Price
$293.69
+7.56% on the day · October 5, 2026
52-week range $88.00 to $296.25
Market cap
$44.3B
P/E
53.9
on FY2025 diluted EPS

Key facts about Illumina, Inc.

Net worth
Illumina, Inc. has a market value (market cap) of $44.3B at the latest share price, and shareholders' equity of $2.8B on its balance sheet at June 28, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $4.3B (-0.7% year on year), with net income of $850M.
Cash flow
In fiscal 2025 operations brought in $1.1B of cash; after $148M of capital spending, free cash flow was $931M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on July 31, 2026 and covers the period to June 28, 2026. Open on SEC EDGAR
Next earnings report
Illumina, Inc.'s next report is expected around October 29, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Illumina, Inc. does

Illumina, Inc. is registered with the SEC under industry code SIC 3826 (Laboratory Analytical Instruments). Its shares trade on NASDAQ under the ticker ILMN.

Revenue and profit by year

Revenue
FY18: $3.3B $3.3B FY18FY19: $3.5B $3.5B FY19FY20: $3.2B $3.2B FY20FY21: $4.5B $4.5B FY21FY22: $4.6B $4.6B FY22FY23: $4.5B $4.5B FY23FY24: $4.4B $4.4B FY24FY25: $4.3B $4.3B FY25
Net income
FY18: $826M $826M FY18FY19: $1B $1B FY19FY20: $656M $656M FY20FY21: $762M $762M FY21FY22: -$4.4B -$4.4B FY22FY23: -$1.2B -$1.2B FY23FY24: -$1.2B -$1.2B FY24FY25: $850M $850M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$4.3B$807M$850M$5.45$931M
2024$4.4B-$833M-$1.2B-$7.69$709M
2023$4.5B-$1.1B-$1.2B-$7.34$283M
2022$4.6B-$4.2B-$4.4B-$28.00$106M
2021$4.5B-$123M$762M$5.04$337M
2020$3.2B$580M$656M$4.45$891M

Full financial statements: income, balance sheet and cash flow

Next report expected around October 29, 2026.

Estimated from its filing rhythm: 52 weeks after its report of October 30, 2025. Not a date the company has announced. See the report calendar

Where ILMN ranks in Health care

Revenue$4.3B
#71 of 750 in Health care · Top 9%
Revenue growth-0.7%
#415 of 532 in Health care · Bottom 22%
Net margin19.6%
#62 of 543 in Health care · Top 11%
Free cash flow margin21.4%
#52 of 489 in Health care · Top 10%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Illumina, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 17, 2026
  2. August 13, 2026
  3. August 12, 2026
  4. August 12, 2026
  5. August 10, 2026
  6. August 10, 2026
  7. August 7, 2026
  8. July 31, 2026
    Quarterly report 10-Q · period to June 28, 2026Revenue rose 9.4% to $1.2B versus the same quarter last year; diluted EPS $1.35 versus $1.49.
  9. July 30, 2026
  10. June 23, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 2, 2026. Insider transactions on SEC

What is ILMN worth? A DCF from its reported cash flow

Insider trades

What the people running Illumina, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $436.5M worth of shares in the last 90 days and bought none on the open market. 0% of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$436.5M
last 90 days
Net sold
2,061,850
$436.5M
DateInsiderWhatSharesPriceValueFiling
September 30, 2026 Ullem Scott B.Director Received as pay 113 $219.80 $24.8K Form 4
September 30, 2026 Meister Keith A.Director Received as pay 107 $219.80 $23.5K Form 4
September 8, 2026 Coletti Julie AnnChief Legal Officer Received as pay 4,549 - - Form 4
September 8, 2026 Coletti Julie AnnChief Legal Officer Received as pay 14,214 - - Form 4
September 5, 2026 Barnard StevenSVP, Chief Technology Officer Shares withheld for tax 408 $211.06 $86.1K Form 4
September 4, 2026 Meister Keith A.Director Soldindirect 7,500 $217.28 $1.6M Form 4
September 4, 2026 Meister Keith A.Director Soldindirect 100,650 $218.39 $22M Form 4
September 4, 2026 Meister Keith A.Director Soldindirect 11,351 $219.18 $2.5M Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ILMN

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Capital World Investors13G, passive 10.3% 15,776,452 May 14, 2026
Vanguard Capital Management13G, passive 5.19% 7,939,213 April 30, 2026

Latest filings below 5%: The Vanguard Group 0% (March 27, 2026); Illumina, Inc. 3.2% (February 17, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 935 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.19,191,398$3.37B+167,808
Capital World Investors15,425,298$2.71B-124,662
Vanguard Portfolio Management LLC6,627,157$1.17B-196,497
Vanguard Capital Management LLC6,587,534$1.16B-7,302
State Street Corp6,507,288$1.14B+77,944
Wcm Investment Management, LLC6,206,701$1.12B+283,528
Fmr LLC4,523,417$795.4M+2,976,556
Aqr Capital Management LLC3,544,465$623.2M-436,615
Primecap Management Co3,514,649$618M+1,447,350
Geode Capital Management, LLC2,946,669$516.7M-104,610
Corvex Management LP2,830,552$497.7M-999,056
Jupiter Topco LLC2,039,763$358.7Mnew
Invesco Ltd.1,994,241$350.6M-663,361
Loomis Sayles & Co L P1,931,948$339.7M-1,011,029
Wellington Management Group Llp1,812,928$318.8M+1,188,004
Massachusetts Financial Services Co1,744,209$308.5M+720,487
Bank of New York Mellon Corp1,671,192$293.8M+171,176
Morgan Stanley1,654,664$290.9M-188,948
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,502,137$264.1M-61,102
Bank of America Corp1,455,287$255.9M-61,342

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

19 insiders reported holding 1,176,591 shares in total, about $345.6M at the last price.

HolderSharesAs of
Meister Keith A.Director 777,237770,350 held indirectly September 30, 2026
Thaysen JacobChief Executive Officer, Director 109,073 March 5, 2026
Barnard StevenSVP, Chief Technology Officer 40,927 September 5, 2026
Dhingra AnkurSVP, Chief Financial Officer 34,264 March 5, 2026
Pegels Kevin CarlChief of Global Operations 29,038 March 5, 2026
Schiller Philip WDirector 22,220 May 21, 2026
Leckman PatriciaSVP, Chief People Officer 21,259 June 5, 2026
Davies Scott MChief Legal Officer 20,338 July 30, 2026
Coletti Julie AnnChief Legal Officer 18,763 September 8, 2026
Siegel Susan EDirector 16,535 May 21, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ILMN

What does Illumina, Inc. do?

Illumina, Inc. is a company in the Health care sector, listed on NASDAQ as ILMN. Its shares trade on NASDAQ under the ticker ILMN.

What is Illumina, Inc.'s net worth?

Illumina, Inc. has a market value (market cap) of $44.3B at the latest share price, and shareholders' equity of $2.8B on its balance sheet at June 28, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Illumina, Inc. profitable?

Yes. Over the twelve months to June 28, 2026 it reported net income of $825M.

When did Illumina, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 31, 2026. It covers the period to June 28, 2026. Its newest filing of any kind is the insider trade from October 2, 2026.

When is Illumina, Inc.'s next earnings report?

Illumina, Inc.'s next report is expected around October 29, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare ILMN with

Compare ILMN with any company

Follow ILMN

Get an email when Illumina, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow ILMN: get an email when it files

Where the numbers come from

Financial figures are the values Illumina, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.